[{"NetIncomeLoss_1_Q1_USD":-90935000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":447000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q1_USD":38.9,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q1_USD":19711000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":0.0,"Depreciation_1_Q1_USD":153000.0,"PaymentsToAcquireInvestments_1_Q1_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1_Q1_USD":54.06,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":458000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":0.0,"InsuranceSettlementsReceivableCurrent_0_Q1_USD":5000000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"AssetsCurrent_0_Q1_USD":272575000.0,"TreasuryStockShares_0_Q1_shares":1994198.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":13148231.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":2668000.0,"TreasuryStockValue_0_Q1_USD":54998000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":0.0,"CommonStockSharesIssued_0_Q1_shares":28176917.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":2078000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":206804000.0,"Assets_0_Q1_USD":278606000.0,"ShareBasedCompensation_1_Q1_USD":5751000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":61064000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":4852000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":25991817.0,"ConvertibleLongTermNotesPayable_0_Q1_USD":271694000.0,"LitigationReserve_0_Q1_USD":18250000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":38.9,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":0.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":14000.0,"AccountsReceivableNetCurrent_0_Q1_USD":17255000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":0.0,"CommonStockValue_0_Q1_USD":26000.0,"InterestPayableCurrent_0_Q1_USD":4169000.0,"AccruedInvestmentIncomeReceivable_0_Q1_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1_Q1_shares":431675.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q1_USD":36.81,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q1_USD":27954000.0,"RestrictedCash_0_Q1_USD":0.0,"OtherPrepaidExpenseCurrent_0_Q1_USD":4305000.0,"IncreaseDecreaseInInventories_1_Q1_USD":3894000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-90935000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-21583000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":217939000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":2520000.0,"Liabilities_0_Q1_USD":548000000.0,"IncreaseDecreaseInOtherAccruedLiabilities_1_Q1_USD":25042000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":2045000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":9808000.0,"AmortizationOfFinancingCosts_1_Q1_USD":400000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":0.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":5751000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-89068000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":17505000.0,"OtherCostAndExpenseOperating_1_Q1_USD":1784000.0,"LiabilitiesCurrent_0_Q1_USD":97893000.0,"AccountsPayableCurrent_0_Q1_USD":30342000.0,"PaymentsOfDebtIssuanceCosts_1_Q1_USD":50000.0,"InterestExpense_1_Q1_USD":8125000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q1_shares":4030575.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":217939000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":2668000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":177000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q1_USD":19711000.0,"AdditionalPaidInCapital_0_Q1_USD":713782000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":172268.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":1183000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":0.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q1_USD":19711000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":1123000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":34163000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-87023000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-928204000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q1_shares":3025257.0,"CommonStockSharesAuthorized_0_Q1_shares":120000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":7978000.0,"OperatingIncomeLoss_1_Q1_USD":-82824000.0,"InventoryNet_0_Q1_USD":20030000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":2543000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":32.12,"PreferredStockValue_0_Q1_USD":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":15.49,"LiabilitiesAndStockholdersEquity_0_Q1_USD":278606000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":11243000.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardGross_1_Q1_USD":0.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":2340000.0,"OperatingExpenses_1_Q1_USD":90802000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-3.5,"OtherLiabilitiesNoncurrent_0_Q1_USD":1290000.0,"StockholdersEquity_0_Q1_USD":-269394000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q1_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":0.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":206804000.0,"IntangibleAssetsNetIncludingGoodwill_0_Q1_USD":56000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":4030575.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":881000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":4845000.0,"Ticker":"ESPR","CIK":"1434868","name":"ESPERION THERAPEUTICS, INC.","OfficialName":"Esperion Therapeutics Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"302940173.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210504"}]